Join
Live feed
·
PRReleasevia Quantisnow
AEON Biopharma Inc. logo

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

ByQuantisnow·Wall Street's wire, on your screen.
AEON· AEON Biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AEON (AEON Biopharma Inc.) and more on Quantisnow.